Navigation Links
New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
Date:9/19/2007

), arthralgia (5.6% vs. 3.5%), nausea (5.1% vs. 4.8%) and diarrhea (5.1% vs. 4.1%). For complete prescribing information for Boniva, see contact information at the end of the news release or go to http://www.Boniva.com.

Boniva is co-promoted by Roche and GSK.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years in the U.S., Roche has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. For additional information about the U.S. pharmaceuticals business, visit our websites: http://www.rocheusa.com or http://www.roche.us.

All trademarks used or mentioned in this release are protected by law.

About GSK

GSK, one of the world's leading research-based pharmaceutical and healthcare companies, is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information, visit GSK on the World Wide Web at http://www.gsk.com.

For more information or full prescribing information, contact:

Roche:

Chris Vancheri/Roche

973-562-2203 or

christopher.vancheri@roche.com

GSK:

Lisa Behrens/GSK

919-483-2839 or

lisa.r.behrens@gsk.com

Fosamax is a registered trademark of Merck & Co., Inc.


'/>"/>
SOURCE Roche and GSK
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 Galmed Pharmaceuticals Ltd. (Nasdaq: ... focused on the development and commercialization of a once-daily, ... cholesterol gallstones, announced today that the U.S. Food and ... Drug, or IND, application.  Such clearance will permit Galmed ... in the United States for ...
(Date:7/22/2014)... a privately-held medical products and technologies company, today announced ... financial officer of the company, effective July 22, 2014. ... and chief financial officer of Elan Corporation, a ... part of a senior team that helped build significant ... Perrigo, a pharmaceutical manufacturer, in December 2013. ...
(Date:7/22/2014)... , July 22, 2014  According to the American ... children spend on digital devices. An AOA survey reports ... 10 and 17 estimate they use an electronic device ... separate AOA survey of parents revealed that only 40 ... device for that same amount of time. Eye doctors ...
Breaking Medicine Technology:Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 2Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 3Galmed Announces FDA Clearance of IND of Armachol for the Treatment of Fatty Liver Disorders 4ConvaTec Names Nigel Clerkin Chief Financial Officer 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4
(Date:7/22/2014)... (PRWEB) July 22, 2014 Marine ... terrorists, environmental destruction, sea-borne illegal immigration, and international ... for regulated and standard maritime security systems. Due ... market has crossed $13.93 billion in 2014 and ... The global maritime security market is expected to ...
(Date:7/22/2014)... 2014 (HealthDay News) -- People who suffer long-term sleep ... rise in blood pressure, a new study suggests. ... and even early death, but few studies have examined ... one of the causes, according to the University of ... had been separated or divorced for about 16 weeks. ...
(Date:7/22/2014)... When is the "right" time? How can women meet ... young family? Choosing to become a mother has a ... academic positions, especially in the physical sciences. Yet many ... book Mom the Chemistry Professor, fifteen inspirational personal accounts ... an academic career in chemistry. , The authors of ...
(Date:7/22/2014)... School of Medicine (BUSM) and Boston Medical Center ... through BMC,s Violence Intervention Advocacy Program (VIAP)--an interventional ... needs of violently injured youthswere less likely to ... behaviors through connections to caring, steady, supportive adults ... findings are reported in the journal Academic ...
(Date:7/22/2014)... Scientists attached radio-frequency identification (RFID) tags to hundreds of individual ... yielded two discoveries: Some foraging bees are much busier than ... their place. , The findings are reported in ... revealed that about 20 percent of the foraging bees in ... and pollen gathered to feed the hive. , "We found ...
Breaking Medicine News(10 mins):Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America Maritime Security Market is Expected to Reach $4.76 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Sleepless Nights After Divorce May Be Tied to Blood Pressure Rise 2Health News:Clients of BMC's violence interventional advocacy program find experience supportive 2Health News:Clients of BMC's violence interventional advocacy program find experience supportive 3Health News:Radio frequency ID tags on honey bees reveal hive dynamics 2
... by researchers at the Johns Hopkins Bloomberg School of Public ... from the disease significantly sooner than those with HIV living ... the shorter survival time measured in the studies suggests that ... in Thailand, may be more virulent than other subtypes of ...
... available to small businesses and ... ... ), a Milwaukee, WI-based national provider of,individual medical, small group and ... network based,here, announced today the formation of a new health care ...
... ... Over 190 Targets, LAKE FOREST, ... of several major,solid tumor indications, generated global sales of $4,964.4 million ... total revenues,of these agents in 2006., Despite this unprecedented market ...
... notice -- creating a,new paradigm for the 21st century, ... representatives from the Center for Medicine in the,Public Interest ... the National Press Club and call for an improved ... about the risks and,benefits of drugs on the market., ...
... today announced that,it will air a lineup of ... this Saturday, December 1. This HIV-focused programming,rounds out ... recently won the Emmy(R) Award for "Outstanding National ... for "Outstanding Special,Programming." The Rap-It- Up campaign also ...
... ... Go, ... natural and specialty food markets, is,celebrating the release of two new products ... quality,yogurt possible., Cascaders are naturally fruit juice sweetened smoothies that contain ...
Cached Medicine News:Health News:Studies suggest HIV subtype more deadly than others 2Health News:Low-Cost Health Care Network Launches in Lubbock 2Health News:Low-Cost Health Care Network Launches in Lubbock 3Health News:Anticancer Drugs Targeting the ErbB (EGFr/HEr2) Pathway Alone Generated Global Sales of Nearly $5 Billion in the First Nine Months of 2007 2Health News:Anticancer Drugs Targeting the ErbB (EGFr/HEr2) Pathway Alone Generated Global Sales of Nearly $5 Billion in the First Nine Months of 2007 3Health News:Drug Safety Experts Call for Increased Patient Involvement 2Health News:Drug Safety Experts Call for Increased Patient Involvement 3Health News:BET Rolls Out a Weekend of Award-Winning, HIV-Themed Programming Commemorating World AIDS Day 2Health News:BET Rolls Out a Weekend of Award-Winning, HIV-Themed Programming Commemorating World AIDS Day 3Health News:Cascade Fresh Yogurt Announces Two Products to Optimize a Healthy Lifestyle 2